Chemokines in autoimmune disease
- 18 October 2001
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 13 (6) , 670-675
- https://doi.org/10.1016/s0952-7915(01)00277-1
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?Annual Review of Immunology, 2001
- CXCR3 Chemokine Receptor Distribution in Normal and Inflamed Tissues: Expression on Activated Lymphocytes, Endothelial Cells, and Dendritic CellsLaboratory Investigation, 2001
- Bonzo/CXCR6 expression defines type 1–polarized T-cell subsets with extralymphoid tissue homing potentialJournal of Clinical Investigation, 2001
- CXCR3 and CCR5 Ligands in Rheumatoid Arthritis SynoviumClinical Immunology, 2001
- Expression and Regulation of Regulated on Activation, Normal T Cells Expressed and Secreted in Thyroid Tissue of Patients with Graves' Disease and Thyroid Autonomy and in Thyroid-Derived Cell PopulationsJournal of Clinical Endocrinology & Metabolism, 2000
- Cc Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune EncephalomyelitisThe Journal of Experimental Medicine, 2000
- Expression of the β-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissueJournal of Neuroimmunology, 2000
- ChemokinesImmunity, 2000
- CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosisJournal of Neuroimmunology, 2000
- A One-Tube Polymerase Chain Reaction Protocol Demonstrates CC Chemokine Overexpression in Graves' Disease GlandsJournal of Clinical Endocrinology & Metabolism, 1999